Pricing Log in Create free account

BlossomHill Therapeutics, Inc. (BLSM) vs Editas Medicine, Inc. (EDIT)

BlossomHill Therapeutics, Inc. and Editas Medicine, Inc. are both Biotechnology companies. BlossomHill Therapeutics, Inc. and Editas Medicine, Inc. are of similar size ($399.3M and $394.5M). BlossomHill Therapeutics, Inc. has the higher net margin (0.00% vs −157.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, BlossomHill Therapeutics, Inc. leads on 6 and Editas Medicine, Inc. on 4.

Valuation

Metric BLSM EDIT Biotechnology median
P/E n/m n/m 10.64
P/S n/m 6.60 9.59
P/B n/m 2.95 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA 0.86 n/m 0.65
EV/Sales n/m 2.79 9.45
Earnings yield (215.71%) (28.85%) (34.69%)
Free cash flow yield (193.74%) (38.78%) (24.02%)

Profitability

Metric BLSM EDIT Biotechnology median
Gross margin — 100.00% 65.59%
Operating margin 0.00% (161.39%) 0.00%
Net margin 0.00% (157.32%) 0.00%
Free cash flow margin 0.00% (255.88%) 0.00%
Return on equity 0.00% (118.82%) (51.96%)
Return on assets 0.00% (33.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BLSM EDIT Biotechnology median
Revenue growth (TTM) — 20.83% 4.59%
EPS growth (last fiscal year) (85.30%) 37.50% 29.88%
Revenue growth, 5-year CAGR — (14.89%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BLSM EDIT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.42 3.19 4.86
Net debt to EBITDA 2.15 0.94 1.01

Dividend

Metric BLSM EDIT Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric BLSM EDIT Biotechnology median
Market cap 394.45m 399.31m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack